Download Citation
Article Source:
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study
Fluge Ø,
Bruland O,
Risa K,
Storstein A,
Kristoffersen EK,
et al.
(2011)
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study.
PLOS ONE 6(10): e26358.
https://doi.org/10.1371/journal.pone.0026358